Is a Normal TSH Synonymous With "Euthyroidism" in Levothyroxine Monotherapy?

Area of Science:

• Endocrinology
• Thyroidology
• Clinical Research

Background:

• Levothyroxine (LT4) monotherapy is the established treatment for hypothyroidism.
• Optimizing LT4 dosage aims to normalize thyroid-stimulating hormone (TSH) levels.

Purpose of the Study:

• To investigate if normalizing serum TSH with LT4 therapy is associated with normal thyroid status markers.
• To evaluate clinical parameters in LT4-treated individuals compared to controls.

Main Methods:

• Analysis of cross-sectional data from the US National Health and Nutrition Examination Survey (2001-2012).
• Comparison of 469 LT4 users with normal TSH against healthy and matched controls.
• Evaluation of 52 clinical parameters using regression analysis for correlations with T4 and T3 levels.

Main Results:

• LT4 users exhibited higher serum total and free T4, and lower serum total and free T3 compared to controls, resulting in a 15-20% lower T3:T4 ratio.
• LT4-treated participants had higher BMI, were more likely to use certain medications (beta-blockers, statins, antidepressants), and reported lower metabolic equivalents.
• Lower TSH levels within the LT4-treated group were associated with higher free T4, similar free T3, and improved lipid profiles (higher HDL, lower LDL and triglycerides).

Conclusions:

• In a large population, LT4 treatment is associated with lower serum T3:T4 ratios.
• LT4 users demonstrated differences in 12 out of 52 evaluated objective and subjective measures compared to controls, even when TSH levels were normalized.